NAVEEN PEMMARAJU
Allopathic & Osteopathic Physicians|Internal Medicine HOUSTON, TX NPI 1578618161
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$196,655.16
- Category: General Payments
- Program years: PY2018–2024
- Record count: 157
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $42,046.92 across 37 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $39,192.00 | 11 |
| Food and Beverage | $1,466.52 | 21 |
| Travel and Lodging | $1,116.15 | 3 |
| Compensation for serving as faculty or as a speaker for a medical education program | $272.25 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $20,467.45 | 7 |
| Incyte Corporation | $10,244.45 | 9 |
| Karyopharm Therapeutics Inc. | $4,205.48 | 2 |
| E.R. Squibb & Sons, L.L.C. | $2,372.00 | 1 |
| Stemline Therapeutics Inc. | $2,370.66 | 2 |
| Tempus AI, Inc | $1,100.00 | 1 |
| ABBVIE INC. | $421.28 | 6 |
| SOBI, INC | $353.21 | 2 |
| Acerta Pharma LLC | $174.42 | 1 |
| TAIHO ONCOLOGY, INC. | $97.83 | 1 |
| Sumitomo Pharma America, Inc. | $85.16 | 1 |
| Astellas Pharma US Inc | $55.77 | 1 |
| Daiichi Sankyo Inc. | $43.68 | 1 |
| Celgene Corporation | $34.97 | 1 |
| Blueprint Medicines Corporation | $20.56 | 1 |
By program year
Records — PY2024 (37)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.